Synovial Fibroblast 3.1: Secretion response of seven primary human synovial fibroblast samples from healthy and rheumatoid arthritis donors to a panel of 3 stimuli and 5 small molecule inhibitors (replicate 1 of 2) - Dataset (ID:20234)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
N2586 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 1 | MIP-1B | 58.0 | 52 | |
N2759 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 1 | MIP-1B | 542.0 | 68 | |
N2759 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 1 | MIP-1B | 63.0 | 63 | |
N2586 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 1 | MIP-1B | 64.0 | 71 | |
RA1869 | IL-1 alpha | 100 | ng/mL | 1 | MIP-1B | 137.0 | 65 | ||||
N2586 | JNK-IN-8 | 3.0 | uM | IL-1 alpha | 100 | ng/mL | 1 | MIP-1B | 113.5 | 82 | |
N2759 | PH-797804 | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 1 | MIP-1B | 490.0 | 68 | |
RA1869 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 1 | MIP-1B | 67.5 | 66 | |
N2759 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 1 | MIP-1B | 66.0 | 66 | |
RA1931 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 1 | MIP-1B | 62.0 | 48 | |
RA1869 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 1 | MIP-1B | 126.5 | 62 | |
N2759 | JNK-IN-8 | 3.0 | uM | IL-1 alpha | 100 | ng/mL | 1 | MIP-1B | 140.0 | 58 | |
RA1931 | JNK-IN-8 | 3.0 | uM | IL-1 alpha | 100 | ng/mL | 1 | MIP-1B | 199.0 | 91 | |
RA1931 | PH-797804 | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 1 | MIP-1B | 568.0 | 55 | |
RA1869 | IL-1 alpha | 100 | ng/mL | 1 | MIP-1B | 209.0 | 70 | ||||
RA1869 | JNK-IN-8 | 3.0 | uM | IL-1 alpha | 100 | ng/mL | 1 | MIP-1B | 102.0 | 60 | |
N2586 | PH-797804 | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 1 | MIP-1B | 156.0 | 77 | |
RA1869 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 1 | MIP-1B | 62.0 | 62 | |
N2759 | IL-1 alpha | 100 | ng/mL | 1 | MIP-1B | 324.0 | 59 | ||||
N2586 | IL-1 alpha | 100 | ng/mL | 1 | MIP-1B | 175.5 | 76 | ||||
RA1931 | IL-1 alpha | 100 | ng/mL | 1 | MIP-1B | 249.0 | 71 | ||||
RA1931 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 1 | MIP-1B | 62.0 | 85 | |
RA1869 | PH-797804 | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 1 | MIP-1B | 89.0 | 67 | |
RA1931 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 1 | MIP-1B | 517.0 | 55 | |
N2759 | IL-1 alpha | 100 | ng/mL | 1 | MIP-1B | 341.5 | 54 |